TMO:NYE-Thermo Fisher Scientific Inc (USD)

EQUITY | Diagnostics & Research | New York Stock Exchange

Last Closing

USD 553

Change

+2.22 (+0.40)%

Market Cap

USD 56.05B

Volume

6.15M

Analyst Target

USD 451.22
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Thermo Fisher Scientific Inc offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-28 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

N/A

USD 188.85B
IQV IQVIA Holdings Inc

N/A

USD 39.03B
A Agilent Technologies Inc

N/A

USD 37.82B
MTD Mettler-Toledo International I..

N/A

USD 31.26B
LH Laboratory Corporation of Amer..

N/A

USD 17.57B
WAT Waters Corporation

N/A

USD 17.22B
DGX Quest Diagnostics Incorporated

N/A

USD 15.40B
RVTY Revvity Inc.

N/A

USD 13.32B
CRL Charles River Laboratories

N/A

USD 10.90B
QGEN Qiagen NV

N/A

USD 9.71B

ETFs Containing TMO

XDNA 9.55 % 0.00 %

N/A

N/A
SYNB Putnam Biorevolution ETF 7.45 % 0.00 %

N/A

USD 5.43M
FHI:CA CI Health Care Giants Cov.. 5.13 % 0.75 %

N/A

CAD 0.09B
BGU-U:CA Bristol Gate Concentrated.. 4.90 % 0.00 %

N/A

CAD 0.11B
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.72 % 0.00 %

N/A

USD 3.56M
DXSI:XETRA Xtrackers - Stoxx Europe .. 4.55 % 0.00 %

N/A

USD 0.02B
AILG 4.51 % 0.00 %

N/A

N/A
XGES:LSE Xtrackers MSCI Genomic He.. 4.41 % 0.00 %

N/A

USD 3.56M
MHCD:CA Middlefield Healthcare Di.. 4.13 % 0.00 %

N/A

CAD 0.16B
IUHC:SW iShares S&P 500 Health Ca.. 4.12 % 0.00 %

N/A

USD 2.40B
ZPDH:F SPDR S&P U.S. Health Care.. 4.12 % 0.00 %

N/A

USD 0.40B
ZPDH:XETRA SPDR S&P U.S. Health Care.. 4.12 % 0.00 %

N/A

USD 0.40B
GXLV:LSE SPDR® S&P® U.S. Health .. 4.12 % 0.00 %

N/A

USD 0.38B
SXLV:SW SPDR S&P U.S. Health Care.. 4.12 % 0.00 %

N/A

N/A
XUHC:F Xtrackers (IE) Public Lim.. 4.01 % 0.00 %

N/A

USD 0.85B
XUHC:XETRA Xtrackers MSCI USA Health.. 4.01 % 0.00 %

N/A

USD 0.85B
XUHC:SW Xtrackers MSCI USA Health.. 4.01 % 0.00 %

N/A

USD 0.82B
XLV Health Care Select Sector.. 3.95 % 0.13 %

N/A

USD 39.08B
QDVG:XETRA iShares S&P 500 Health Ca.. 3.95 % 0.00 %

N/A

USD 2.05B
QDVG:F iShares S&P 500 Health Ca.. 3.92 % 0.00 %

N/A

USD 2.09B
WH2E:XETRA Invesco Markets II plc - .. 3.83 % 0.00 %

N/A

USD 2.46M
IYH iShares U.S. Healthcare E.. 3.80 % 0.43 %

N/A

USD 3.31B
LS:CA Middlefield Healthcare & .. 3.73 % 2.21 %

N/A

CAD 0.16B
VHT Vanguard Health Care Inde.. 3.60 % 0.10 %

N/A

USD 17.67B
PINK Simplify Exchange Traded .. 3.58 % 0.00 %

N/A

USD 0.12B
DRUG:AU BetaShares Global Healthc.. 3.50 % 0.00 %

N/A

USD 0.17B
FHLC Fidelity® MSCI Health Ca.. 3.46 % 0.08 %

N/A

USD 3.04B
CDNA:CA CI Bio-Revolution ETF 3.16 % 0.00 %

N/A

CAD 5.70M
RXL ProShares Ultra Health Ca.. 3.02 % 0.95 %

N/A

USD 0.09B
XDWH:F Xtrackers (IE) Public Lim.. 2.86 % 0.00 %

N/A

USD 2.60B
XDWH:XETRA Xtrackers MSCI World Heal.. 2.86 % 0.00 %

N/A

USD 2.60B
XWHS:LSE Xtrackers MSCI World Heal.. 2.86 % 0.00 %

N/A

USD 2.68B
HEAW:LSE SPDR® MSCI World Health .. 2.85 % 0.00 %

N/A

USD 0.59B
WHEA:SW SPDR MSCI World Health Ca.. 2.85 % 0.00 %

N/A

N/A
ABIE:XETRA AXA IM ACT Biodiversity E.. 2.62 % 0.00 %

N/A

N/A
GMVM:XETRA VanEck Morningstar US Sus.. 2.58 % 0.00 %

N/A

USD 0.53B
MOAT:SW VanEck Morningstar US Sus.. 2.58 % 0.00 %

N/A

N/A
LRGE ClearBridge Large Cap Gro.. 2.30 % 0.59 %

N/A

USD 0.37B
ABIT:XETRA AXA IM ACT Biodiversity E.. 2.28 % 0.00 %

N/A

USD 0.41B
ABIT:F AXA IM ACT Biodiversity E.. 2.28 % 0.00 %

N/A

N/A
ABIE:F AXA IM ACT Biodiversity E.. 2.28 % 0.00 %

N/A

N/A
HYLG Global X Funds - Global X.. 1.94 % 0.00 %

N/A

USD 2.85M
DOCG:LSE L&G Healthcare Breakthrou.. 1.75 % 0.00 %

N/A

USD 0.07B
DOCT:LSE L&G Healthcare Breakthrou.. 1.75 % 0.00 %

N/A

USD 0.07B
PHE:CA Purpose Tactical Hedged E.. 1.64 % 0.95 %

N/A

CAD 3.03M
DFUV Dimensional US Marketwide.. 1.20 % 0.00 %

N/A

USD 10.31B
JPST JPMorgan Ultra-Short Inco.. 0.74 % 0.00 %

N/A

USD 23.71B
CURE Direxion Daily Healthcare.. 0.00 % 1.06 %

N/A

USD 0.20B
IBLN 0.00 % 0.64 %

N/A

N/A
IXJ iShares Global Healthcare.. 0.00 % 0.46 %

N/A

USD 4.01B
JHMH 0.00 % 0.46 %

N/A

N/A
LDUR PIMCO Enhanced Low Durati.. 0.00 % 1.02 %

N/A

USD 0.87B
JMIN 0.00 % 0.12 %

N/A

N/A
ACT Enact Holdings Inc 0.00 % 0.75 %

N/A

USD 4.82B
KORP American Century Diversif.. 0.00 % 0.45 %

N/A

USD 0.25B
BGU:CA Bristol Gate Concentrated.. 0.00 % 0.85 %

N/A

CAD 0.11B
HWF:CA 0.00 % 0.00 %

N/A

N/A
CGAA:CA CI Global Asset Allocatio.. 0.00 % 0.00 %

N/A

CAD 0.02B
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

N/A

USD 0.85M
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

N/A

USD 0.85M
XHC:CA iShares Global Healthcare.. 0.00 % 0.65 %

N/A

CAD 0.61B
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.69 %

N/A

CAD 0.01B
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.00 %

N/A

USD 1.69B
IUHC:LSE iShares S&P 500 USD Healt.. 0.00 % 0.00 %

N/A

USD 2.39B
MOAT:LSE VanEck Morningstar US Sus.. 0.00 % 0.00 %

N/A

USD 0.45B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

N/A

USD 0.38B
WHEA:LSE SPDR® MSCI World Health .. 0.00 % 0.00 %

N/A

USD 0.58B
XDWH:LSE Xtrackers MSCI World Heal.. 0.00 % 0.00 %

N/A

USD 2.65B
XFVT:LSE Xtrackers FTSE Vietnam Sw.. 0.00 % 0.00 %

N/A

USD 0.35B
XSHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

N/A

USD 0.82B
XUHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

N/A

USD 0.82B
XVTD:LSE Xtrackers - FTSE Vietnam .. 0.00 % 0.00 %

N/A

USD 0.30B
HIG-U:CA 0.00 % 0.00 %

N/A

N/A
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
IXJ:AU iShares Global Healthcare.. 0.00 % 0.00 %

N/A

USD 1.36B
DWEQ 0.00 % 0.00 %

N/A

N/A
MOGB:LSE VanEck Morningstar US Sus.. 0.00 % 0.00 %

N/A

USD 0.44B
PFUT Putnam Sustainable Future.. 0.00 % 0.00 %

N/A

USD 0.28B
SROI Calamos Antetokounmpo Glo.. 0.00 % 0.00 %

N/A

USD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.18% 85% B 60% D-
Dividend Return 0.15% 29% F 3% F
Total Return 4.33% 85% B 53% F
Trailing 12 Months  
Capital Gain 5.99% 77% C+ 55% F
Dividend Return 0.15% 17% F 2% F
Total Return 6.14% 77% C+ 44% F
Trailing 5 Years  
Capital Gain 88.30% 100% F 85% B
Dividend Return 1.70% 20% F 5% F
Total Return 90.00% 100% F 83% B
Average Annual (5 Year Horizon)  
Capital Gain 16.97% 85% B 82% B
Dividend Return 17.19% 77% C+ 80% B-
Total Return 0.22% 17% F 5% F
Risk Return Profile  
Volatility (Standard Deviation) 23.27% 69% C- 45% F
Risk Adjusted Return 73.86% 100% F 90% A-
Market Capitalization 56.05B 100% F 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 36.24 50% 17%
Price/Book Ratio 4.62 46% 19%
Price / Cash Flow Ratio 25.64 38% 11%
Price/Free Cash Flow Ratio 21.90 31% 12%
Management Effectiveness  
Return on Equity 13.62% 62% 70%
Return on Invested Capital 8.92% 54% 61%
Return on Assets 4.82% 54% 71%
Debt to Equity Ratio 67.01% 38% 49%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.